Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Debut has achieved 100-300% year-over-year revenue growth for 3 years and operates in 77 regions[1]. The company's BeautyORB™ platform screens upward of 50 billion ingredients to discover novel bioactive compounds, with a capability to screen 21,000 molecules per second using deep learning[2][8]. The platform has generated over 60 million data points with 100 million projected over the next 12 months[8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Debut Biotechnology.